Rapid Micro Biosystems Inc
NASDAQ:RPID

Watchlist Manager
Rapid Micro Biosystems Inc Logo
Rapid Micro Biosystems Inc
NASDAQ:RPID
Watchlist
Price: 2.28 USD 0.88% Market Closed
Market Cap: $104.4m

Rapid Micro Biosystems Inc
Non-Reccuring Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Rapid Micro Biosystems Inc
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
Rapid Micro Biosystems Inc
NASDAQ:RPID
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Non-Reccuring Items
-$362m
CAGR 3-Years
-37%
CAGR 5-Years
-32%
CAGR 10-Years
-8%
Danaher Corp
NYSE:DHR
Non-Reccuring Items
-$672m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-21%
Waters Corp
NYSE:WAT
Non-Reccuring Items
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Agilent Technologies Inc
NYSE:A
Non-Reccuring Items
-$116m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IQVIA Holdings Inc
NYSE:IQV
Non-Reccuring Items
-$111m
CAGR 3-Years
-58%
CAGR 5-Years
-11%
CAGR 10-Years
-10%
No Stocks Found

Rapid Micro Biosystems Inc
Glance View

Rapid Micro Biosystems, Inc. is an innovative life sciences technology company. The company is headquartered in Lowell, Massachusetts and currently employs 220 full-time employees. The company went IPO on 2021-07-15. The firm provides automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct platform automates and modernizes the manual microbial quality control (MQC), testing workflows used in pharmaceutical manufacturing operations across the globe. The Growth Direct platform helps on the manufacturing floor, unlocking the power of in-line/at-the-line MQC automation to deliver results with data regulations, and decision making that its customers rely on to ensure the supply of healthcare products. The Company’s Growth Direct platform is the automated MQC solution. The firm offers two consumables plates to capture test samples for analysis on the Growth Direct, which includes an Environmental Monitoring (EM), consumable and a Water/Bioburden (W/BB) consumable.

RPID Intrinsic Value
1.46 USD
Overvaluation 36%
Intrinsic Value
Price $2.28

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett